Balance Sheet Details

9 Months Ended

Sep. 30, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Balance Sheet Details

5. Balance Sheet Details

Inventory consisted of the following (in thousands):

	September 30, 2024		December 31, 2023
Finished goods	$	19,129	$	5,001
Work in process		25,433		4,134
Raw material		42,178		31,312
	$	86,740	$	40,447
Reported as:
Inventory	$	61,041	$	35,819
Long-term inventory		25,699		4,628
Total	$	86,740	$	40,447

Amount reported as long-term inventory consisted of raw materials as of September 30, 2024 and December 31, 2023. The Company has raw materials beyond a one year production plan that help limit the exposures from potential supply interruption. Those raw materials beyond the one year production plan were classified as long-term inventory.

Accrued liabilities consisted of the following (in thousands):

	September 30, 2024		December 31, 2023
Accrued sales allowances	$	135,943	$	90,718
Accrued contingent payments		79,583		29,583
Accrued compensation and benefits		37,022		42,718
Accrued consulting and professional fees		28,580		18,804
Accrued research and development services		22,063		32,883
Current portion of lease liabilities		8,949		9,405
Other		12,724		12,600
	$	324,864	$	236,711